U.S. markets open in 8 hours 10 minutes
  • S&P Futures

    3,857.75
    +12.75 (+0.33%)
     
  • Dow Futures

    31,165.00
    +69.00 (+0.22%)
     
  • Nasdaq Futures

    13,380.50
    +86.25 (+0.65%)
     
  • Russell 2000 Futures

    2,160.90
    +3.20 (+0.15%)
     
  • Crude Oil

    53.28
    +0.04 (+0.08%)
     
  • Gold

    1,874.20
    +7.70 (+0.41%)
     
  • Silver

    26.08
    +0.31 (+1.22%)
     
  • EUR/USD

    1.2137
    +0.0004 (+0.04%)
     
  • 10-Yr Bond

    1.0900
    0.0000 (0.00%)
     
  • Vix

    21.58
    -1.66 (-7.14%)
     
  • GBP/USD

    1.3701
    +0.0067 (+0.49%)
     
  • USD/JPY

    103.3870
    -0.5050 (-0.49%)
     
  • BTC-USD

    34,667.50
    +4.88 (+0.01%)
     
  • CMC Crypto 200

    686.27
    -14.34 (-2.05%)
     
  • FTSE 100

    6,740.39
    +27.44 (+0.41%)
     
  • Nikkei 225

    28,756.86
    +123.40 (+0.43%)
     

Miravo Healthcare™ to Host Investor Webcast on January 28, 2021 at 2:00 p.m. EST

·4 min read

MISSISSAUGA, ON, Jan. 14, 2021 /PRNewswire/ - Nuvo Pharmaceuticals Inc. (TSX: MRV) (OTCQX: MRVFF) d/b/a Miravo Healthcare (Miravo or the Company), a Canadian focused healthcare company with global reach and a diversified portfolio of commercial products, today announced it will host an investor presentation webcast on Thursday, January 28 at 2:00 p.m. EST (11:00 a.m. PST).

Miravo Healthcare (CNW Group/Nuvo Pharmaceuticals Inc.)
Miravo Healthcare (CNW Group/Nuvo Pharmaceuticals Inc.)

During the webcast, Jesse Ledger, Miravo's President & Chief Executive Officer will provide a PowerPoint presentation that will cover key areas of Miravo's business. During the presentation, investors will have an opportunity to ask questions through an interactive Q&A portal.

To access the webcast or to ask questions during the live event, please pre-register at the following link: https://event.webcasts.com/starthere.jsp?ei=1419796&tp_key=e642921200

An archived version of the webcast and presentation will be available on the Presentations & Webcasts page of the Company's website, https://www.miravohealthcare.com/investors/presentations-webcasts/ following the event.

About Miravo Healthcare

Miravo is a Canadian focused, healthcare company with global reach and a diversified portfolio of commercial products. The Company's products target several therapeutic areas, including pain, allergy, and dermatology. The Company's strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets. Miravo's head office is located in Mississauga, Ontario, Canada, the international operations are located in Dublin, Ireland and the Company's manufacturing facility is located in Varennes, Québec, Canada. The Varennes facility operates in a Good Manufacturing Practices (GMP) environment respecting the U.S, Canada and E.U. GMP regulations and is regularly inspected by Health Canada and the U.S. Food and Drug Administration. For additional information, please visit www.miravohealthcare.com.

Forward-Looking Statements
This press release contains "forward-looking information" as defined under Canadian securities laws (collectively, "forward-looking statements"). The words "plans", "expects", "does not expect", "goals", "seek", "strategy", "future", "estimates", "intends", "anticipates", "does not anticipate", "projected", "believes" or variations of such words and phrases or statements to the effect that certain actions, events or results "may", "will", "could", "would", "should", "might", "likely", "occur", "be achieved" or "continue" and similar expressions identify forward-looking statements. In addition, any statements that refer to expectations, intentions, projections or other characterizations of future events or circumstances contain forward-looking statements.

Forward-looking statements are not historical facts but instead represent management's expectations, estimates and projections regarding future events or circumstances, including the anticipated receipt of certain milestone and royalty payments, the anticipated launch of certain products and the potential impact of COVID-19. Such forward-looking statements are qualified in their entirety by the inherent risks, uncertainties and changes in circumstances surrounding future expectations which are difficult to predict and many of which are beyond the control of the Company. Forward-looking statements are necessarily based on a number of estimates and assumptions that, while considered reasonable by management of the Company as of the date of this press release, are inherently subject to significant business, economic and competitive uncertainties and contingencies and may prove to be incorrect. Material factors and assumptions used to develop the forward-looking statements, and material risk factors that could cause actual results to differ materially from the forward-looking statements, include but are not limited to, the validity of the '907 and '285 Patents claims, the outcome of ongoing patent litigation, the potential impact of COVID-19 on the Company's operations, business and financial results and other factors, many of which are beyond the control of Miravo. Additional factors that could cause Miravo's actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the risk factors included in Miravo's most recent Annual Information Form dated February 24, 2020 under the heading "Risks Factors", and as described from time to time in the reports and disclosure documents filed by Miravo with Canadian securities regulatory agencies and commissions. These and other factors should be considered carefully and readers should not place undue reliance on Miravo's forward-looking statements. Forward-looking statements should not be read as guarantees of future performance or results and will not necessarily be accurate indications of whether or not the times at or by which such performance or results will be achieved.

All forward-looking statements are based only on information currently available to the Company and are made as of the date of this press release. Except as expressly required by applicable Canadian securities law, the Company assumes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise. All forward-looking statements in this press release are qualified by these cautionary statements.

Cision
Cision

View original content to download multimedia:http://www.prnewswire.com/news-releases/miravo-healthcare-to-host-investor-webcast-on-january-28-2021-at-200-pm-est-301208032.html

SOURCE Nuvo Pharmaceuticals Inc.